- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of CD44 and the survival in glioma: a meta-analysis
Authors
Keywords
-
Journal
BIOSCIENCE REPORTS
Volume 40, Issue 4, Pages -
Publisher
Portland Press Ltd.
Online
2020-03-31
DOI
10.1042/bsr20200520
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peripheral blood test provides a practical method for glioma evaluation and prognosis prediction
- (2019) Zhi‐Liang Wang et al. CNS Neuroscience & Therapeutics
- The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
- (2019) Zhenpeng Wang et al. Frontiers in Oncology
- Identification and Targeting of Stem Cell-Activated Pathways in Cancer Therapy
- (2019) Alfredo Budillon et al. Stem Cells International
- Prognostic value of stem cell markers in glioblastoma
- (2019) Francesc Alameda et al. BIOMARKERS
- Hyaluronan-CD44 axis orchestrates cancer stem cell functions
- (2019) Spyros S. Skandalis et al. CELLULAR SIGNALLING
- Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas
- (2019) Chongxian Hou et al. JOURNAL OF NEURO-ONCOLOGY
- Cancer stem cell (CSC) resistance drivers
- (2019) Masoud Najafi et al. LIFE SCIENCES
- Primary and metastatic brain tumours in adults: summary of NICE guidance
- (2018) Alex Bates et al. BMJ-British Medical Journal
- Primary and metastatic brain tumours in adults: summary of NICE guidance
- (2018) Alex Bates et al. BMJ-British Medical Journal
- Association of Glioblastoma Multiforme Stem Cell Characteristics, Differentiation, and Microglia Marker Genes with Patient Survival
- (2018) Sandra Bien-Möller et al. Stem Cells International
- Prediction value of unmeasurable MR enhancement at early stage after gross-total resection on the survival state of patients with high-grade glioma
- (2018) Guanmin Quan et al. JOURNAL OF NEURO-ONCOLOGY
- Primary brain tumours in adults
- (2018) Sarah Lapointe et al. LANCET
- Significance of Glioma Stem-Like Cells in the Tumor Periphery That Express High Levels of CD44 in Tumor Invasion, Early Progression, and Poor Prognosis in Glioblastoma
- (2018) Masahiro Nishikawa et al. Stem Cells International
- Targeting Cancer Stemness in the Clinic: From Hype to Hope
- (2018) Caner Saygin et al. Cell Stem Cell
- Mesenchymal subtype of glioblastomas with high DNA-PKcs expression is associated with better response to radiotherapy and temozolomide
- (2017) Baptiste Pinel et al. JOURNAL OF NEURO-ONCOLOGY
- Neurological update: gliomas and other primary brain tumours in adults
- (2017) Sebastian Brandner et al. JOURNAL OF NEUROLOGY
- Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma
- (2017) Alexandra Y Tsidulko et al. TUMOR BIOLOGY
- CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells
- (2017) Elinn Johansson et al. Cell Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis
- (2016) Yangkun Luo et al. Cancer Cell International
- The role of CD44 in glioblastoma multiforme
- (2016) Kelly L. Mooney et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Immunohistochemical expression of stem cell markers CD44 and nestin in glioblastomas: Evaluation of their prognostic significance
- (2016) Elia Guadagno et al. PATHOLOGY RESEARCH AND PRACTICE
- Cancer stem cell markers: premises and prospects
- (2015) Madhura Murar et al. Biomarkers in Medicine
- Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis
- (2015) Xintao Li et al. Scientific Reports
- Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis
- (2015) Yunyuan Zhang et al. Journal of Orthopaedic Surgery and Research
- FGF2 as a potential prognostic biomarker for proneural glioma patients
- (2014) Linda Sooman et al. ACTA ONCOLOGICA
- Prognostic Value of CD44 Variant exon 6 Expression in Non-Small Cell Lung Cancer: a Meta-analysis
- (2014) Shuang Zhao et al. Asian Pacific Journal of Cancer Prevention
- The prognostic value of CD44 expression in gastric cancer: A meta-Analysis
- (2014) Yansu Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis
- (2014) Jianqiang Chen et al. BMC CANCER
- CD44-Mediated Adhesion to Hyaluronic Acid Contributes to Mechanosensing and Invasive Motility
- (2014) Yushan Kim et al. MOLECULAR CANCER RESEARCH
- TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells
- (2013) J. Fu et al. NEURO-ONCOLOGY
- The developing cancer stem-cell model: clinical challenges and opportunities
- (2012) Louis Vermeulen et al. LANCET ONCOLOGY
- CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma
- (2010) Y. Xu et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now